Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Sophia Genetics SA - SIC # 7372 - PREPACKAGED SOFTWARE
Ticker
Exchange
SIC #
Website
Latest Ticker
SOPH
Nasdaq
7372
https://www.sophiagenetics.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Sophia Genetics SA
SOPHiA GENETICS Announces Validation of Novel Clinical Trial Assay Together with Precision for Medicine at World Clinical Biomarkers & CDx 2024
- Sep 5th, 2024 12:30 pm
SOPHiA GENETICS Unveils New Generation of the SOPHiA DDMTM Platform at Morgan Stanley Healthcare Conference 2024
- Sep 4th, 2024 10:00 am
SOPHiA GENETICS to Present at the 22nd Annual Morgan Stanley Healthcare Conference and 9th Annual TD Cowen FutureHealth Conference
- Aug 28th, 2024 5:30 pm
Sophia Genetics secures CE mark for DDM analytics platform under EU’s IVDR
- Aug 14th, 2024 1:13 pm
SOPHiA DDM™ Platform Certified Under IVDR
- Aug 14th, 2024 7:00 am
SOPHiA GENETICS (SOPH) Loses -30.47% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
- Aug 12th, 2024 1:35 pm
What Makes SOPHiA GENETICS (SOPH) a New Buy Stock
- Aug 9th, 2024 4:00 pm
SOPHiA GENETICS Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
- Aug 8th, 2024 11:45 am
SOPHiA GENETICS SA (SOPH) Reports Q2 Loss, Lags Revenue Estimates
- Aug 6th, 2024 11:55 am
SOPHiA GENETICS Reports Second Quarter 2024 Results
- Aug 6th, 2024 10:45 am
SOPHiA GENETICS Announces L'hôpital Universitaire Avicenne is Live on SOPHiA DDM™
- Jul 29th, 2024 2:30 pm
SOPHIA GENETICS Announces Expanded Relationship with Canada-Based OncoHelix
- Jul 24th, 2024 3:59 pm
SOPHiA GENETICS to Announce Financial Results for Second Quarter 2024 on August 6, 2024
- Jul 23rd, 2024 10:45 am
SOPHiA GENETICS SA's (NASDAQ:SOPH) top owners are retail investors with 44% stake, while 27% is held by institutions
- Jul 14th, 2024 2:30 pm
India’s Dhiti Omics deploys SOPHiA DDM platform for solid tumour testing
- Jul 5th, 2024 8:32 am
India-Based Dhiti Omics is Now Live on SOPHiA DDM™
- Jul 4th, 2024 6:30 am
SOPHiA GENETICS Publishes Results of 2024 Annual General Meeting
- Jun 24th, 2024 1:47 pm
SOPHiA GENETICS Launches New Residual Acute Myeloid (RAM) Application
- Jun 24th, 2024 6:00 am
SOPHiA GENETICS Announces Kepler Uniklinikum is Live on SOPHiA DDM™ Platform
- Jun 13th, 2024 10:00 am
SOPHiA GENETICS Launches Global Consortium, SOPHiA UNITY, to Accelerate Cancer Research, Drug Development, and Data-Driven Patient Care
- May 30th, 2024 5:18 pm
Scroll